The global Hemophilia Treatment Market is anticipated USD 14 billion by 2025; according to a new research study published by Global Market Insights, Inc. increasing global prevalence of hemophilia will drive the hemophilia treatment market in the upcoming years. The rise in number of people suffering from hemophilia and increasing cases of genetic abnormalities will result in propelling the market's growth.
An increase in demand for hemophilia treatment to fulfill the unmet needs of people across the globe will propel global market growth. According to the National Hemophilia Foundation, over 75% people with hemophilia in the world still receive inadequate or no treatment for hemophilia. The wide range of scope for market penetration and demand for hemophilia treatment will significantly impact the industry growth in the future.
Improving healthcare infrastructure in developing regions of Asia Pacific and Latin America region will augment the hemophilia treatment market growth. Increasing investment in R&D activities, growing government initiatives and healthcare infrastructure will assist in business growth. Moreover, a rise in the number of improved infrastructures related to public and private healthcare facilities will foster growth opportunities for the hemophilia market.
Lack of awareness among the patients regarding hemophilia and the treatment associated with it will be a major market growth impeding factor. A majority of hemophilic patients live in developing countries that have little or no access to hemophilia treatment, leading to increased morbidity and mortality. Lack of awareness among people, a low level of recognition and diagnosis of hemophilic patients, and a dearth of skilled healthcare professionals will impede the market's growth.